GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| Free cash flow (TTM) | YoY | 5-year CAGR |
|---|---|---|
| $12.9B | +38.1% | 4.7% |
| Free cash flow (TTM) | $12.9B |
|---|---|
| YoY | +38.1% |
| 5-year CAGR | 4.7% |
Free cash flow
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $9.5B | −8.2% |
| 2024 | $10.3B | +38.9% |
| 2023 | $7.4B | −11.1% |
| 2022 | $8.3B | −22.8% |
| 2021 | $10.8B | +43.7% |
| 2020 | $7.5B | −9.6% |
| 2019 | $8.3B | +11.3% |
| 2018 | $7.5B | — |
| 2013 | $3.0B | — |